menu
    • menu
    [{"orgOrder":0,"company":"ZabBio","sponsor":"KBio","pharmaFlowCategory":"D","therapeuticArea":"Rare Diseases and Disorders","country":"U.S.A","productType":"Undisclosed","year":"2022","type":"Partnership","leadProduct":"Undisclosed","moa":"Undisclosed","graph1":"Rare Diseases and Disorders","graph2":"Preclinical","graph3":"ZabBio","amount2":0,"highestDevelopmentShortName":"Preclinical","therapeuticAreaShortName":"Rare Diseases","amount2New":0,"dosageForm":"Injection","sponsorNew":"ZabBio \/ ZabBio","highestDevelopmentStatusID":"4","companyTruncated":"ZabBio \/ ZabBio"},{"orgOrder":0,"company":"ZabBio","sponsor":"Gansu Provincial Maternal and Child Health Care Hospital | Boston University | Old Dominion University","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"U.S.A","productType":"Antibody, Unconjugated","year":"2025","type":"Inapplicable","leadProduct":"KB15A","moa":"Undisclosed","graph1":"Undisclosed","graph2":"Phase I","graph3":"ZabBio","amount2":0,"highestDevelopmentShortName":"Ph I","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Film","sponsorNew":"ZabBio \/ Gansu Provincial Maternal and Child Health Care Hospital | Boston University | Old Dominion University","highestDevelopmentStatusID":"6","companyTruncated":"ZabBio \/ Gansu Provincial Maternal and Child Health Care Hospital | Boston University | Old Dominion University"}]

    Find Clinical Drug Pipeline Developments & Deals by ZabBio

    Menu

    ZabBio

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            ZabBio

                            U.S.A arrow
                            COMPAMED
                            Not Confirmed

                            ZabBio

                            U.S.A arrow
                            COMPAMED
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : KB15A

                            Therapeutic Area : Undisclosed

                            Study Phase : Phase I

                            Sponsor : Gansu Provincial Maternal and Child Health Care Hospital | Boston University | Old Dominion University

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Phase 1 Study of Intravaginal KB15A

                            Details : KB15A is an antibody candidate, which is currently being evaluated in Phase I clinical studies for the treatment of undefined medical condition.

                            Product Name : Undisclosed

                            Product Type : Antibody, Unconjugated

                            Upfront Cash : Inapplicable

                            October 29, 2025

                            Lead Product(s) : KB15A

                            Therapeutic Area : Undisclosed

                            Highest Development Status : Phase I

                            Sponsor : Gansu Provincial Maternal and Child Health Care Hospital | Boston University | Old Dominion University

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            02

                            ZabBio

                            U.S.A arrow
                            COMPAMED
                            Not Confirmed

                            ZabBio

                            U.S.A arrow
                            COMPAMED
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Undisclosed

                            Therapeutic Area : Rare Diseases and Disorders

                            Study Phase : Discovery

                            Recipient : KBio

                            Deal Size : Undisclosed

                            Deal Type : Partnership

                            DEALS_DEV arrow-down

                            KBio Announces Strategic Partnership with ZabBio to Discover and Develop Antibody Therapeutics

                            Details : Under the terms of the agreement, KBio will have development rights to select assets within ZabBio’s current pipeline of antibody therapies – including a late-stage preclinical anti-fungal mAb – as well as future products discovered under the colla...

                            Product Name : Undisclosed

                            Product Type : Undisclosed

                            Upfront Cash : Undisclosed

                            September 13, 2022

                            Lead Product(s) : Undisclosed

                            Therapeutic Area : Rare Diseases and Disorders

                            Highest Development Status : Discovery

                            Recipient : KBio

                            Deal Size : Undisclosed

                            Deal Type : Partnership

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth